Flutamide
Who holds supplier records for Flutamide? 4 organisations hold a current record for Flutamide: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (1), Finland (1), India (1) and Spain (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Flutamide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/flutamide
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Flutamide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CURIA ITALY SRLItalyCEP Company GMP cert on recordActive DMF 12807 · latest filing Dec 1997
- FERMION OYFinlandCEP Company GMP cert on recordActive DMF 11522 · latest filing May 1995
- IndiaCEP Company GMP cert on record
- SpainCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Flutamide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| CURIA ITALY S.R.L. Origgio | IT | CEP 2000-049 - Rev 08 Flutamide, Unmilled; milled | May 2026 | Inspected Apr 2025 Italy |
| FERMION OY Espoo | FI | CEP 2002-134 - Rev 05 Flutamide | Feb 2025 | Inspected Feb 2026 Finland |
| CORAL DRUGS PRIVATE LIMITED New Delhi | IN | CEP 2001-416 - Rev 04 Flutamide | Oct 2024 | — |
| DERIVADOS QUIMICOS S.A.U. Alcantarilla | ES | CEP 2002-159 - Rev 06 Flutamide | Apr 2024 | Inspected Jun 2025 Spain |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (9)
Organisations whose Type II DMFs for Flutamide are no longer active. These show a past filing, not current supply.
Show all 9 historical records
- Germany · Inactive DMF 23507 · filed Jan 2010
- China · Inactive DMF 19951 · filed Nov 2006
- IROTEC LABORATORIESInactive DMF 14719 · filed Feb 2000
- Germany · Inactive DMF 14705 · filed Feb 2000
- India · Inactive DMF 14637 · filed Dec 1999
- TRIQUIM SAInactive DMF 12790 · filed Dec 1997
- Gedeon Richter UsaInactive DMF 10497 · filed Sept 1993
- South Africa · Inactive DMF 8679 · filed Aug 1990
- GANES CHEMICALS INC PENNSVILLE DIVInactive DMF 4144 · filed Apr 1981
Overview
Flutamide is a nonsteroidal antiandrogen used primarily to treat prostate cancer. It works by binding to androgen receptors, preventing the action of endogenous androgens in the prostate, which can inhibit tumor growth.
Chemical identity
- IUPAC name
- 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
- Canonical SMILES
- CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
- InChIKey
- MKXKFYHWDHIYRV-UHFFFAOYSA-N
- Synonyms
- Eulexin API, eulexin, nsc-215876, sch 13521, sch-13521
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Androgen Receptor Inhibitor
- Mechanism of action
- Androgen Receptor Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Flutamide?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Flutamide: CURIA ITALY SRL (Italy), FERMION OY (Finland), CORAL DRUGS PVT LTD (India) and DERIVADOS QUIMICOS SAU (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Flutamide Drug Master Files are active?
CURIA ITALY SRL (DMF 12807) and FERMION OY (DMF 11522). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Flutamide records mean?
9 organisations have only inactive Type II DMFs for Flutamide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Flutamide have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Flutamide on the EDQM register, including CURIA ITALY S.R.L. Origgio (IT), FERMION OY Espoo (FI), CORAL DRUGS PRIVATE LIMITED New Delhi (IN) and DERIVADOS QUIMICOS S.A.U. Alcantarilla (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Flutamide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Flutamide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.